Medicare Enrolled
Dr. Amine Bourbia, MD
Pulmonary Disease · Rome, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bourbia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bourbia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bourbia
Dr. Amine Bourbia is a pulmonary disease specialist in Rome, GA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Bourbia performed 2,050 Medicare services across 1,429 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bourbia received a total of $14,595 from 38 pharmaceutical and/or device companies across 309 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bourbia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 18% volume in GA
$14,595 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,050
Medicare services
Top 18% in GA for pulmonary disease
1,429
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~171 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
471 | $87 | $157 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
288 | $161 | $442 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
230 | $89 | $169 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
123 | $58 | $507 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
123 | $113 | $243 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
122 | $130 | $303 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
111 | $17 | $105 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
88 | $16 | $80 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
87 | $13 | $25 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
67 | $22 | $155 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
56 | $35 | $120 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
56 | $36 | $110 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
51 | $0 | $5 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
46 | $55 | $670 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
27 | $28 | $120 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
23 | $8 | $15 |
| Drainage of fluid from chest cavity with insertion of indwelling tube | 18 | $91 | $1,640 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
13 | $72 | $845 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $63 | $105 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
13 | $29 | $40 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
12 | $133 | $705 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
12 | $66 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,595
Total received (2018-2024)
Avg $2,085/year across 7 years
Top 16% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
309
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,327 (50.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,268 (49.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,448
2023
$1,685
2022
$8,737
2021
$1,361
2020
$356
2019
$989
2018
$18
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$326
INTUITIVE SURGICAL, INC.
$208
Amgen Inc.
$100
Grifols USA, LLC
$98
GlaxoSmithKline, LLC.
$95
GENZYME CORPORATION
$85
Takeda Pharmaceuticals U.S.A., Inc.
$71
HARMONY BIOSCIENCES LLC
$67
Insmed, Inc.
$59
Actelion Pharmaceuticals US, Inc.
$56
ANI Pharmaceuticals, Inc.
$46
Merck Sharp & Dohme LLC
$46
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Regeneron Healthcare Solutions, Inc.
$39
Axsome Therapeutics, Inc.
$29
Baxter Healthcare
$28
Mylan Specialty L.P.
$27
United Therapeutics Corporation
$22
Top 3 companies account for 43.8% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$7,869
GlaxoSmithKline, LLC.
$1,254
Boston Scientific Corporation
$989
AstraZeneca Pharmaceuticals LP
$896
Actelion Pharmaceuticals US, Inc.
$505
Boehringer Ingelheim Pharmaceuticals, Inc.
$473
Mylan Specialty L.P.
$319
Grifols USA, LLC
$255
GENZYME CORPORATION
$225
INTUITIVE SURGICAL, INC.
$208
Insmed, Inc.
$176
Takeda Pharmaceuticals U.S.A., Inc.
$166
Amgen Inc.
$150
United Therapeutics Corporation
$143
ANI Pharmaceuticals, Inc.
$112
SANOFI-AVENTIS U.S. LLC
$96
Merck Sharp & Dohme LLC
$74
Regeneron Healthcare Solutions, Inc.
$71
HARMONY BIOSCIENCES LLC
$67
AbbVie Inc.
$67
Novartis Pharmaceuticals Corporation
$51
PFIZER INC.
$41
Mallinckrodt Hospital Products Inc.
$38
Harmony Biosciences LLC
$35
Philips Electronics North America Corporation
$32
JAZZ PHARMACEUTICALS INC.
$30
Allergan, Inc.
$29
Axsome Therapeutics, Inc.
$29
Baxter Healthcare
$28
Gilead Sciences, Inc.
$26
Johnson & Johnson Health Care Systems Inc.
$22
Sunovion Pharmaceuticals Inc.
$20
Inspire Medical Systems, Inc.
$19
Tactile Systems Technology Inc
$18
La Jolla Pharmaceutical Company
$18
Inogen, Inc.
$17
Alexion Pharmaceuticals, Inc.
$14
ABBVIE INC.
$12
Top 3 companies account for 69.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACQUIRE · ACTHAR · AIRSUPRA · ANORO ELLIPTA · AREXVY · AVYCAZ · Arikayce · BREZTRI · BREZTRI AEROSPHERE · COREDX · DAVINCI XI · DUPIXENT · Da Vinci Surgical System · FASENRA · Flexitouch Plus · GENERAL PULMONARY · GIAPREZA · GLASSIA · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · ORENITRAM · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · SPIRIVA RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · ULTRAFLEX · UPTRAVI · Ultomiris · WAKIX · WINREVAIR · XOLAIR · XYWAV · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Pulmonary diseases within 10 mi
5
Per 100K population
5.1
County median income
$62,540
Nearest hospital
ADVENTHEALTH REDMOND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bourbia is a clinical cardiology specialist, with above-average Medicare volume (top 18% in GA), with speaking/promotional industry engagement in the top 16% of GA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bourbia experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bourbia performed 471 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bourbia receive payments from pharmaceutical companies?
Yes. Dr. Bourbia received a total of $14,595 from 38 companies across 309 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bourbia's costs compare to other pulmonary diseases in Rome?
Dr. Bourbia's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bourbia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Rome
Browse pulmonary diseases in Rome ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology